How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients Read more →
Biomarkers are reshaping oncology trial design Read more →
AstraZeneca’s faith in IL-33 inhibitor continues to pay off with latest phase 3 COPD win Read more →